OptimizeRx Corporation (NASDAQ: OPRX) is a digital health company that offers life sciences support to patients and clinicians. It encourages patients to stick to their treatment plans by making them more affordable.
Why should Investors Sell?
Valuation Methodology: Price/Earnings Multiple Based Relative Valuation
(Source: Analysis by Kalkine Group)
OPRX's share price has fallen 33.62% in the past three months and is currently leaning towards the 52-week low of USD 37.85. We have valued the stock using the price/earnings multiple based relative valuation methodology and arrived at a target price of USD 39.88. Considering the long cash conversion cycle, overvalued multiples, weak margins, current valuation, and other technical indicators, we recommend a "SELL" rating on the stock at the current price of USD 48.87, up 0.49% as of February 16, 2022, at 11:56 AM ET.
OPRX's 3-Year Technical Price Chart. (Source: REFINITIV, Analysis by Kalkine Group)
* The reference data in this report has been partly sourced from REFINITIV.
* All forecasted figures and industry information have been taken from REFINITIV.